Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial

Yoshiyuki Nagumo, Tomokazu Kimura, Hitoshi Ishikawa, Yuta Sekino, Kazushi Maruo, Bryan J. Mathis, Yukio Kageyama, Hiroki Ushijima, Jun Kamei, Hideomi Yamashita, Haruhito Azuma, Keiji Nihei, Taku Naiki, Natsuo Tomita, Yasuyuki Kobayashi, Kotaro Yoshio, Takashi Matsumoto, Tadamasa Yoshitake, Takahiro Osawa, Kentaro Nishioka, Yuki Kita, Takashi Mizowaki, Kyosuke Hattori, Toyonori Tsuzuki, Koichi Hashimoto, Hiroyuki Nishiyama

Open source

DOI
10.1016/j.eururo.2025.12.019
Published
2026-01
Container
European Urology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2025.12.019,
  title = {Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial},
  author = {Yoshiyuki Nagumo and Tomokazu Kimura and Hitoshi Ishikawa and Yuta Sekino and Kazushi Maruo and Bryan J. Mathis and Yukio Kageyama and Hiroki Ushijima and Jun Kamei and Hideomi Yamashita and Haruhito Azuma and Keiji Nihei and Taku Naiki and Natsuo Tomita and Yasuyuki Kobayashi and Kotaro Yoshio and Takashi Matsumoto and Tadamasa Yoshitake and Takahiro Osawa and Kentaro Nishioka and Yuki Kita and Takashi Mizowaki and Kyosuke Hattori and Toyonori Tsuzuki and Koichi Hashimoto and Hiroyuki Nishiyama},
  year = {2026},
  journal = {European Urology},
  doi = {10.1016/j.eururo.2025.12.019},
  url = {https://doi.org/10.1016/j.eururo.2025.12.019}
}

RIS

TY  - JOUR
TI  - Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial
AU  - Yoshiyuki Nagumo
AU  - Tomokazu Kimura
AU  - Hitoshi Ishikawa
AU  - Yuta Sekino
AU  - Kazushi Maruo
AU  - Bryan J. Mathis
AU  - Yukio Kageyama
AU  - Hiroki Ushijima
AU  - Jun Kamei
AU  - Hideomi Yamashita
AU  - Haruhito Azuma
AU  - Keiji Nihei
AU  - Taku Naiki
AU  - Natsuo Tomita
AU  - Yasuyuki Kobayashi
AU  - Kotaro Yoshio
AU  - Takashi Matsumoto
AU  - Tadamasa Yoshitake
AU  - Takahiro Osawa
AU  - Kentaro Nishioka
AU  - Yuki Kita
AU  - Takashi Mizowaki
AU  - Kyosuke Hattori
AU  - Toyonori Tsuzuki
AU  - Koichi Hashimoto
AU  - Hiroyuki Nishiyama
PY  - 2026
JO  - European Urology
DO  - 10.1016/j.eururo.2025.12.019
UR  - https://doi.org/10.1016/j.eururo.2025.12.019
ER  - 

APA

Nagumo, Y., Kimura, T., Ishikawa, H., Sekino, Y., Maruo, K., Mathis, B. J., Kageyama, Y., Ushijima, H., Kamei, J., Yamashita, H., Azuma, H., Nihei, K., Naiki, T., Tomita, N., Kobayashi, Y., Yoshio, K., Matsumoto, T., Yoshitake, T., Osawa, T., Nishioka, K., Kita, Y., Mizowaki, T., Hattori, K., Tsuzuki, T., Hashimoto, K., & Nishiyama, H. (2026). Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial. European Urology. https://doi.org/10.1016/j.eururo.2025.12.019

Source records